Poliovirus 3C proteinase inhibition by organotelluranes

Biological Chemistry

Volumn 392, Issue 6, 2011, Pages 587-591

  Gouvea, Iuri E ^a   Santos, Jorge A N ^a   Burlandy, Fernanda M ^b   Tersariol, Ivarne L S ^c   Da Silva, Edson E ^b   Juliano, Maria A ^a   Juliano, Luiz ^a   Cunha, Rodrigo L O R ^a,d  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

^d UNIVERSIDADE FEDERAL DO ABC   (Brazil)

Author keywords

antiviral; organotellurides; picornavirus; protease inhibitor; proteinase; tellurium

Indexed keywords

3C PROTEINASE; AMMONIUM TRICHLORO (DIOXOETHYLENE O,O') TELLURATE; BIS VINYLIC ORGANOTELLURANE; CATHEPSIN B; CATHEPSIN K; CATHEPSIN L; CATHEPSIN S; CHLORO TELLUROXETANE; ORGANOTELLURIUM DERIVATIVE; PROTEINASE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; DRUG STRUCTURE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; RHABDOMYOSARCOMA; VIROGENESIS; VIRUS REPLICATION;

CYSTEINE ENDOPEPTIDASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; MOLECULAR STRUCTURE; ORGANOMETALLIC COMPOUNDS; POLIOVIRUS; STRUCTURE-ACTIVITY RELATIONSHIP; TELLURIUM; VIRAL PROTEINS;

PICORNAVIRIDAE; POLIOVIRUS;

EID: 79958059008     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2011.059     Document Type: Article

References (33)

1. Albeck, M., Tamari, T., and Sredni, B. (1989). Synthesis and properties of ammonium trichloro(dioxyethylene-O,O9)tellurate (as- 101) - a new immunomodulating compound. Synthesis 8, 635-636.
2. Albeck, A., Weitman, H., Sredni, B., and Albeck, M. (1998). Tellurium compounds: selective inhibition of cysteine proteases and model reaction with thiols. Inorg. Chem. 37, 1704-1712. (Pubitemid 128485891)
3. Baici, A., Schenker, P., Wachter, M., and Ruedi, P. (2009). 3-Fluoro- 2,4-dioxa-3-phosphadecalins as inhibitors of acetylcholinesterase. A reappraisal of kinetic mechanisms and diagnostic methods. Chem. Biodivers. 6, 261-282.
4. Barrett, A.J. and Kirschke, H. (1981). Cathepsin-B, cathepsin-H, and cathepsin-L. Methods Enzymol. 80, 535-561.
5. Borenfreund, E. and Puerner, J.A. (1985). Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol. Lett. 24, 119-124. (Pubitemid 15103513)
6. Brubacher, L.J. and Glick, B.R. (1974). Inhibition of papain by N-ethylmaleimide. Biochemistry 13, 915-920.
7. Collett, M.S., Neyts, J., and Modlin, J.F. (2008). A case for developing antiviral drugs against polio. Antiviral Res. 79, 179-187.
8. Cunha, R.L.O.R., Urano, M.E., Chagas, J.R., Almeida, P.C., Bincoletto, C., Tersariol, I.L.S., and Comasseto, J.V. (2005). Tellurium- based cysteine protease inhibitors: evaluation of novel organotellurium(IV) compounds as inhibitors of human cathepsin B. Bioorg. Med. Chem. Lett. 15, 755-760. (Pubitemid 40143161)
9. Cunha, R.L.O.R., Gouvea, I.E., Feitosa, G.P., Alves, M.F., Bromme, D., Comasseto, J.V., Tersariol, I.L., and Juliano, L. (2009a). Irreversible inhibition of human cathepsins B, L, S and K by hypervalent tellurium compounds. Biol. Chem. 390, 1205-1212.
10. Cunha, R.L.O.R., Gouvea, I.E., and Juliano, L. (2009b). A glimpse on biological activities of tellurium compounds. An. Acad. Bras. Cienc. 81, 393-407.
11. Friedman, M., Bayer, I., Letko, I., Duvdevani, R., Zavaro-Levy, O., Ron, B., Albeck, M., and Sredni, B. (2009). Topical treatment for human papillomavirus-associated genital warts in humans with the novel tellurium immunomodulator AS101: assessment of its safety and efficacy. Br. J. Dermatol. 160, 403-408.
12. Gouvea, I.E., Judice, W.A.S., Cezari, M.H.S., Juliano, M.A., Juhasz, T., Szeltner, Z., Polgar, L., and Juliano, L. (2006). Kosmotropic salt activation and substrate specificity of poliovirus protease 3C. Biochemistry 45, 12083-12089. (Pubitemid 44497834)
13. Jaulent, A.M., Fahy, A.S., Knox, S.R., Birtley, J.R., Roque-Rosell, N., Curry, S., and Leatherbarrow, R.J. (2007). A continuous assay for foot-and-mouth disease virus 3C protease activity. Anal. Biochem. 368, 130-137. (Pubitemid 47198566)
14. Johnson, L.A., Moon, K.E., and Eisenberg, M. (1988). Inactivation of chymotrypsin and human skin chymase: kinetics of timedependent inhibition in the presence of substrate. Biochim. Biophys. Acta 953, 269-279.
15. Kalechman, Y., Sredni, B., Weinstein, T., Freidkin, I., Tobar, A., Albeck, M., and Gafter, U. (2003). Production of the novel mesangial autocrine growth factors GDNF and IL-10 is regulated by the immunomodulator AS101. J. Am. Soc. Nephrol. 14, 620-630. (Pubitemid 36246005)
16. Kong, J.S., Venkatraman, S., Furness, K., Nimkar, S., Shepherd, T.A., Wang, Q.M., Aube, J., and Hanzlik, R.P. (1998). Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication. J. Med. Chem. 41, 2579-2587. (Pubitemid 28321907)
17. Korkmaz, B., Attucci, S., Juliano, M.A., Kalupov, T., Jourdan, M.L., Juliano, L., and Gauthier, F. (2008). Measuring elastase, proteinase 3 and cathepsin G activities at the surface of human neutrophils with fluorescence resonance energy transfer substrates. Nat. Protoc. 3, 991-1000. (Pubitemid 351818687)
18. Leyssen, P., De Clercq, E., and Neyts, J. (2008). Molecular strategies to inhibit the replication of RNA viruses. Antiviral Res. 78, 9-25.
19. Mosimann, S.C., Cherney, M.M., Sia, S., Plotch, S., and James, M.N. (1997). Refined X-ray crystallographic structure of the poliovirus 3C gene product. J. Mol. Biol. 273, 1032-1047. (Pubitemid 27501158)
20. Okun, E., Arumugam, T.V., Tang, S.C., Gleichmann, M., Albeck, M., Sredni, B., and Mattson, M.P. (2007). The organotellurium compound ammonium trichloro(dioxoethylene-O,O9)tellurate enhances neuronal survival and improves functional outcome in an ischemic stroke model in mice. J. Neurochem. 102, 1232-1241. (Pubitemid 47174227)
21. Palmenberg, A.C. (1990). Proteolytic processing of picornaviral polyprotein. Annu. Rev. Microbiol. 44, 603-623.
22. Piovan, L., Alves, M.F.M., Juliano, L., Brömme, D., Cunha, R.L.O.R., and Andrade, L.H. (2011). Structure-activity relationships of hypervalent organochalcogenanes as inhibitors of cysteine cathepsins V and S. Bioorg. Med. Chem. 19, 2009-2014.
23. Reed, L.J. and Muench, H. (1938). A simple method of estimating fifty percent endpoints. Am. J. Hygiene 27, 487-493.
24. Sarkany, Z. and Polgar, L. (2003). The unusual catalytic triad of poliovirus protease 3C. Biochemistry 42, 516-522. (Pubitemid 36105770)
25. Sarkany, Z., Szeltner, Z., and Polgar, L. (2001). Thiolate-imidazolium ion pair is not an obligatory catalytic entity of cysteine peptidases: the active site of picornain 3C. Biochemistry 40, 10601-10606. (Pubitemid 32816671)
26. Schechter, I. and Berger, A. (1967). On size of active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27, 157-162.
27. Seipelt, J., Guarne, A., Bergmann, E., James, M., Sommergruber, W., Fita, I., and Skern, T. (1999). The structures of picornaviral proteinases. Virus Res. 62, 159-168. (Pubitemid 29393116)
28. Vonsover, A., Loya, S., Sredni, B., Albeck, M., Gotliebstematsky, T., Araf, O., and Hizi, A. (1992). Inhibition of the reverse-transcriptase activity and replication of human immunodeficiencyvirus type-1 by as-101 in vitro. Aids Res. Hum. Retroviruses 8, 613-623. (Pubitemid 23130915)
29. Wang, Q.M. and Johnson, R.B. (2001). Activation of human rhinovirus- 14 3C protease. Virology 280, 80-86.
30. Weidner, J.R. and Dunn, B.M. (1991). Development of synthetic peptide-substrates for the poliovirus-3C proteinase. Arch. Biochem. Biophys. 286, 402-408.
31. World Health Organization (2004). Polio Laboratory Manual. Available at: http://www.who.int/vaccines/en/poliolab/WHOPolio- Manual-9.pdf.
32. Zeni, G., Chieffi, A., Cunha, R.L.O.R., Zukerman-Schpector, J., Stefani, H.A., and Comasseto, J.V. (1999). Addition reaction of p-methoxyphenyltellurium trichloride to 3-hydroxy alkynes. Organometallics 18, 803-806. (Pubitemid 129658999)
33. Zukerman-Schpector, J., Haiduc, I., Dabdoub, M.J., Biazzotto, J.C., Braga, A.L., Dornelles, L., and Caracelli, I. (2002). Dichlorobis( 2-chloro-2-phenyl-vinyl)Te(IV) and dibromo-bis(2-bromo-2- phenyl-vinyl)Te(IV): supramolecular self-assembly through different pi-aryl interactions. Z. Kristallogr. 217, 609-613.